staining and real-time PCR were used to detect the expression of IFNg from the aorta of ApoE-/-mice.
g from the aorta of ApoE-/-mice.
RESULTS
Our results show that the percentages of CD4þ IFN-gþ from the spleens were decreased after treatment with different dose of Danlou Tablet groups compared to the model group, greatly decreased with high-dose DLT group(model group vs DLT-H group :13.80AE2.00 vs 8.23AE1.65, p < 0.01). Immunohistochemical staining and real-time PCR for aorta revealed that the IFN-g was decreaed with Danlou Tablet dose-dependent(the fold changes of IFN-g:model group vs DLT-L group: 2.96AE0.87 vs 2.10AE1.28, P < 0.05; model group vs DLT-M group: 2.96AE0.87 vs1.68AE0.40, P < 0.01; model group vs DLT-H group: 2.96AE0.87 vs1.24AE0.15, P < 0.01). The findings suggest that Danlou Tablet could markedly attenuates progression of atherosclerosis by decreasing the expression of IFN-g and suppressing inflammation.
CONCLUSIONS Our findings demonstrate that Danlou Tablet could decrease the expression of IFN-g or restain the artery-infiltrating T cells, especially the Th1 cells activated or suppressed inflammation and attenuated progression of atherosclerosis via weaken the Th1-IFN-g pathway.
GW26-e2323
Regulation and mechanism of Guizhi Decoction on Diabetic Cardiac Autonomic Neuropathy Yuehua Jiang, 1 Dufang Ma, 2 Jinlong Yang, 1 Xiao Li 1 1 Affiliated Hospital of Shandong University of Traditional Chinese Medicine; 2 Shandong University of Traditional Chinese Medicine OBJECTIVES To investigate the effects of Guizhi decoction (a longused harmonic prescription in traditional Chinese medicine) on cardiac autonomic neuropathy (CAN) in streptozotocin (STZ)-induced diabetic rats. With the establishment of chemical sympathetic sprouting and sympathectomy rat models, we explored the protective mechanism of Guizhi decoction on the cardiac sympathetic remodeling.
METHODS

1) After induction of diabetic rats with STZ for four weeks, mecobalamin
and Guizhi decoction were administered to the STZ rats for 4 weeks. Heart rate variability (HRV) were recorded, and contents of nerve growth factor (NGF), growth associated protein 43(GAP-43) and ciliary neurotrophic factor (CNTF) in myocardium as well as the density of tyrosine hydroxylase (TH) and choline acetyltransferase (ChAT) in the right atrium (RA) were respectively measured using ELISA and immunohistochemical staining. 2) Cardiac sympathetic sprouting rats were induced with 4-Methylcatechol (4-MC) for 30 days. Metoprolol and Guizhi decoctions were separately administered to the rats for 30 days. Meanwhile, we established chemical sympathectomy rats with 6-Hydroxydopamine (6-OHDA) for 3 days. Mecobalamin and Guizhi decoctions were separately administered to the rats for 10 days. Contents of GAP-43, TH and ChAT in the cardiac tissue were examined and distribution of TH-positive nerve fibers was observed. Besides, serum myocardial enzyme levels and changes of myocardial morphology were observed in 6-OHDA rats. OBJECTIVES Endothelial dysfunction is a central hallmark of diabetes, delaying endothelial healing in diabetic patients following angioplasty. The epigenetic abnormalities are increasingly considered to be relevant to the pathogenesis of diabetic complications. We here investigated the therapeutic potential of histone demethylase JMJD2A and its substrate histone H3 lysine 9 trimethylation (H3K9me3) on reendothelialization in a vascular injury model of diabetic rats.
RESULTS
METHODS JMJD2A inhibition was achieved either by chemical inhibitor 2,4-pyridinedicarboxylic acid (2,4-PDCA) or small interfering RNA (siRNA) both in vitro and in vivo studies. In vitro, we examined the proliferative, migratory and angiogenic capacities of human umbilical vein endothelial cells (HUVECs) in response to high glucose (HG). Flow cytometry was performed to detect the apoptosis and the expressions of apoptosis-associated genes were assessed by real-time PCR and western blot. Immunoprecipitation (ChIP) assay was conducted to examine the modification of H3K9me3 at related genes' promoters. In vivo, common carotid artery balloon injury was developed in high-fat diets (60% fat) and low-dose streptozotocin (35 mg/ kg) induced diabetic rats. The reendothelialization was quantified withEvens blue staining and immunohistochemical staining.
RESULTS Both in HG-treated HUVECs and balloon-injured arteries of diabetic rats, the global expression of JMJD2A was increased whereas H3K9me3 was decreased. In vitro, JMJD2A inhibition either by 2,4-PDCA (0.5mM) or by siRNA (20nM) accelerated HUVECs proliferation, migration and tube formation in response to HG, accompanied by reduced expression of TNF-a and suppressed apoptosis (downregulated caspase3, caspase9, Bax and upregulated Bcl-2). ChIP assay indicated that the potential mechanism was relevant to the increased H3K9me3 at the promoter of TNF-a and then the transcriptional silencing of TNF-a. Complementary in vitro studies showed that JMJD2A inhibition promoted reendothelialization in diabetic rats.
CONCLUSIONS JMJD2A inhibition promotes reendothelialization after arterial injury in diabetic rats via accelerated proliferation, migration and suppressed apoptosis of endothelial cells.
GW26-e5383 Pioglitazone Decreases Plaque Thrombosis by Attenuating Plaque
Inflammation. An In Vivo Study Using 18F-FDG PET/CT Quanming Zhao, Mingduo Zhang, Xin Zhao, Tingting Feng Beijing Anzhen Hospital, Capital Medical University OBJECTIVES Pioglitazone, a clinically used insulin sensitizer, has appeared to have an anti-atherosclerotic effect. The aims of this study is to determine whether pioglitazone can reduce the number of plaque thrombosis incidences and whether decreasing plaque inflammation is the mechanism by which pioglitazone reduces plaque thromboses in an atherosclerotic model.
METHODS 20 male New Zealand white rabbits were randomly divided into two groups: Atherosclerosis group (Group A, n¼10) and middlepioglitazone-treated group (Group P, n¼10). Atherosclerosis was induced in all rabbits by intermittent high-cholesterol diet and endothelial denudation. From the ninth week, the rabbits in group P received pioglitazone (10 mg$kg -1 $d -1 ) in addition to the diet, till the end of experiment. PET/CT scans were performed at 8 week and 18 week in all survival rabbits, to obtain FDG uptake parameters (mean standardized uptake value, SUVmean and maximal standardized uptake value, SUVmax). Concomitantly, serum samples were obtained for analysis of blood glucose (G), triglycerides (TG), total cholesterol (Ch), HDL, LDL, hs-CRP and matrix metalloproteinase-9 concentration (MMP-9). All survival rabbits underwent 2 pharmacological triggerings to induce plaque rupture at 18 week. After pharmacological triggering, all rabbits were euthanatized, aortic histopathological analysis were performed.
RESULTS 20 male New Zealand white rabbits were randomly divided into two groups: Atherosclerosis group (Group A, n¼10) and 
